Intracranial hemorrhage in patient treated with rivaroxaban

  • Michelle Molina Department of Neurology, New York Medical College, Valhalla, NY, United States.
  • Virany H. Hillard Department of Neurology, New York Medical College, Valhalla, NY, United States.
  • Robert Fekete | robertfekete@hotmail.com Department of Neurology, New York Medical College, Valhalla, NY, United States.

Abstract

Rivaroxaban is an oral factor Xa inhibitor used for stroke prevention in atrial fibrillation. There are currently no evidence-based guidelines for the treatment of hemorrhagic side effects of factor Xa inhibitors. We report a case of a thalamic hemorrhage in an 84 year-old right-handed female on rivaroxaban for treatment of atrial fibrillation. The patient had fallen down steps and became unresponsive. She was found to have diffuse scattered acute subarachnoid hemorrhage as well as intraventricular hemorrhage. Neurosurgical intervention was not required in this case, but controversy over decision making to pursue pro-coagulant therapy in the setting of worsening hemorrhage requiring emergent surgery is discussed.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.
Published
2014-03-28
Info
Issue
Section
Case Reports
Keywords:
rivaroxaban, Factor Xa inhibitor
Statistics
  • Abstract views: 1619

  • PDF: 452
  • HTML: 176
How to Cite
Molina, M., Hillard, V. H., & Fekete, R. (2014). Intracranial hemorrhage in patient treated with rivaroxaban. Hematology Reports, 6(1). https://doi.org/10.4081/hr.2014.5283